|
| Press Releases |
|
 |
|
| Monday, March 18, 2024 |
|
|
Essex Bio-Technology Posts Sound 2023 Annual Financial Results, Revenue Up 29.5%, Profit Up 22.1% |
| Essex Bio-Technology Limited ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2023. more info >> |
|
| Wednesday, August 16, 2023 |
|
|
Essex Bio-Technology Posts Sound 2023 Interim Financial Results, Revenue Up 37.1%, Profit Up 22% |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the interim results for the six months ended 30 June 2023 ("the period under review").
more info >> |
|
| Wednesday, July 26, 2023 |
|
|
The phase 1/2 clinical trial of Bevacizumab for treatment of Ophthalmic Diseases completed |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that a phase 1/2 clinical trial of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
| Friday, April 14, 2023 |
|
|
Essex and Osteopore Entered into Exclusive Distribution Agreement for Oral Maxillofacial products in Singapore |
| Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Majeton Pte. Ltd. ("Majeton"), has entered into an exclusive Distribution Agreement with Osteopore Limited ("Osteopore") to promote and sell Osteopore's dental and oral maxillofacial products ("Products") in Singapore. more info >> |
|
| Tuesday, April 11, 2023 |
|
|
Essex and Gunze Shenzhen Entered into Exclusive Agency Agreement for PELNAC Absorbable Dressing in Mainland China |
| Essex Bio-Technology Ltd. ("Essex" or the "Group", Stock Code: 1061.HK) is pleased to announce that its wholly-owned subsidiary, Essex Medipharma (Zhuhai) Co., Ltd. ("Essex Medipharma"), has entered into an Agency Agreement ("Agency Agreement") with Gunze Medical Devices (Shenzhen) Ltd. more info >> |
|
| Wednesday, March 8, 2023 |
|
|
Essex Bio-Technology Announces 2022 Annual Financial Results |
Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2022.
more info >> |
|
| Wednesday, February 22, 2023 |
|
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited ("Essex Bio-Investment") and Zhuhai Essex Bio-Pharmaceutical Co. Ltd ("Zhuhai Essex") more info >> |
|
| Friday, February 10, 2023 |
|
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that the first patient in the United States (US) was dosed in a global multi-centre phase 3 clinical trial (NCT04740671) of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
| Thursday, October 13, 2022 |
|
|
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech |
| Essex Bio-Technology Ltd (Essex Bio-Technology; HKG: 1061) wishes to announce that wholly-owned subsidiary Essex Bio-Investment Ltd (Essex Bioinvestment) on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed in relation to SkQ1, an active pharmaceutical ingredient, from Mitotech S.A. more info >> |
|
| Tuesday, August 16, 2022 |
|
|
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022" |
| Essex Bio-Technology Ltd ("EssexBio" or the "Group", Stock Code: 1061.HK) is pleased and honoured to announce that it is included in "Forbes Asia's 200 Best Under A Billion 2022" - for the Group's outstanding long-term sustainable development across a variety of metrics. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Seamless Shopping for K-Culture Lovers: Bringko Expands Cross-Border Services with New Free Shipping Promotion 
Nov 9, 2024 07:00 HKT/SGT
|
|
|
MANAMAURI, the High-Quality Energy Drink Brand, Joins EastBridge Global Investments for Major International Expansion
Nov 9, 2024 06:00 HKT/SGT
|
|
|
Military Metals Announces Appointment of Mark Saxon to Its Board of Directors
Nov 8, 2024 23:58 HKT/SGT
|
|
|
ITC's Final Decision Confirms Innoscience's Customers Remain Unaffected by the Innoscience-EPC Patent Row
Nov 8, 2024 20:23 HKT/SGT
|
|
|
The 32nd Hong Kong International Optical Fair attracts some 13,000 buyers
Nov 8, 2024 20:10 HKT/SGT
|
|
|
Dynasty Wins One Silver and One Bronze Medals at 2024 HKIWSC
Nov 8, 2024 19:32 HKT/SGT
|
|
|
Hong Kong Fashion Designers Association Celebrates 40th Anniversary
Nov 8, 2024 17:56 HKT/SGT
|
|
|
Three Ways AI Tools Can Help Drive Efficiencies for Small Businesses
Nov 8, 2024 16:00 HKT/SGT
|
|
|
TRIO Launches 360 Botslab's Smart Home Security Products in Malaysia, Introducing Advanced AI Solutions to Local Consumers
Nov 8, 2024 14:00 HKT/SGT
|
|
|
International Symposium 'Creating the Future' Sparks Discussions on Technology, Society, and Future Civilization
Nov 8, 2024 14:00 HKT/SGT
|
|
|
ArborChat Outperforms the Market by 750 Basis Points Over a Year
Nov 8, 2024 10:49 HKT/SGT
|
|
|
Transgene and NEC Present New Data Confirming Clinical Proof of Principle for Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at SITC 2024
Nov 8, 2024 10:31 JST
|
|
|
Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
Nov 7, 2024 22:15 HKT/SGT
|
|
|
Representatives from Over 87 Countries to Participate in the International Symposium 'Creating the Future'
Nov 7, 2024 22:00 HKT/SGT
|
|
|
AdSure Invites Advertisers to Access Top-Quality Finance and Insurance Leads - 10% Conversion Guarantee for Top Funnel Live Leads
Nov 7, 2024 22:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
